Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shares rose 10% on Wednesday . The stock traded as high as $2.17 and last traded at $1.65. Approximately 2,822 shares were traded during trading, a decline of 80% from the average daily volume of 14,372 shares. The stock had previously closed at $1.50.
Silence Therapeutics Price Performance
The company’s 50-day moving average price is $1.20 and its 200 day moving average price is $1.45.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Featured Articles
- Five stocks we like better than Silence Therapeutics
- Most active stocks: Dollar volume vs share volume
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- What Is WallStreetBets and What Stocks Are They Targeting?
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- What Are the FAANG Stocks and Are They Good Investments?
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.